LIVN today
$90.12-$0.86 (-0.95%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourBearish
1 hourBearish
15 minBearish
5 minBearish
Daily trend turns up above $85.76
Key levels
Resistance$99.38
Resistance$93.89
Support$88.00
Support$82.28
Latest news & SEC filings
AnalystBarclays keeps LivaNova at Overweight, lifts price target to $120
AnalystBarclays keeps Overweight rating on LivaNova, lifts target to $120
AnalystBaird keeps Outperform rating on LivaNova, lifts price target to $111
All LIVN news →About LivaNova
LivaNova is a medical device company that operates in two main segments: Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides products for heart-lung machines and related consumables used during cardiac surgery. The Neuromodulation segment offers devices for vagus nerve stimulation to treat epilepsy and depression. The company sells its products to hospitals and healthcare providers in the United States, Europe, and other regions worldwide.
Based on the company's 10-K filed Feb 25, 2026.
Nasdaq · Healthcare
LivaNova PLC (LIVN)
What Is the Price Target for LIVN?
SEPT Low Target
$78.20
SEPT Mid Target
$92.00
SEPT High Target
$105.80
Analyst Consensus
$92.00
Is LIVN a Buy or Sell Right Now?
Thesis
- •Revenue growing 10.7% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for LIVN.
Start Free Trial →Is LIVN Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$99.91
48
Moat Score
NARROW
4/9
Piotroski Score
2.2
Altman Z-Score
What Is Smart Money Doing with LIVN?
Insider Signal
NEUTRAL
0 buys / 3 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Story Brooke | director | Sale | 2,300 | $187K | Sep 4, 2026 |
| Bianchi Francesco | director | Sale | 1,650 | $132K | Aug 31, 2026 |
| Bianchi Francesco | director | Sale | 1,800 | $136K | May 26, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →LIVN Growth Story
Revenue YoY
10.7%
3yr Revenue CAGR
10.8%
EPS Growth YoY
-483.62%
FCF Growth YoY
27.5%
Revenue Trend
STABLE
Dark Pool Trades for LIVN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for LIVN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:44 | $90.98 | 7,246 | $$659K | SELL |
| 21:00:17 | $90.98 | 2,148 | $$195K | SELL |
| 21:00:17 | $90.98 | 4,700 | $$428K | SELL |
| 21:00:17 | $90.98 | 2,500 | $$227K | SELL |
| 21:00:00 | $90.98 | 2,084 | $$190K | BUY |
5 dark pool trades shown · $$1.7M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for LIVN
PREVIEWSEPT Investing provides real-time options flow tracking for LIVN, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $100 | Nov 20 | 9 | $$80 | 1 | SWEEP |
| CALL | $105 | Nov 20 | 9 | $$30 | 1 | SWEEP |
| CALL | $105 | Nov 20 | 9 | $$30 | 1 | SWEEP |
| CALL | $100 | Nov 20 | 9 | $$60 | 1 | SWEEP |
| CALL | $105 | Nov 20 | 9 | $$30 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for LivaNova PLC (LIVN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →LIVN — frequently asked questions
What is LIVN stock price today?
LivaNova PLC (LIVN) is at $90.12, down 0.95% (-$0.86) at the Nov 12, 2026 close.
Why is LIVN stock moving today?
Latest LIVN news — Nov 9, 2026: Barclays keeps LivaNova at Overweight, lifts price target to $120 · Nov 9, 2026: Barclays keeps Overweight rating on LivaNova, lifts target to $120
What is the LIVN price target?
The average analyst price target for LIVN is $92.00, ranging from $76 to $105, based on 7 analysts. Latest: Barclays initiates on Oct 7, 2026.
What do analysts rate LIVN?
Analyst ratings for LIVN: 1 Buy, 8 Hold, 0 Sell — consensus Hold.
Did LIVN beat earnings?
LIVN last reported on Aug 5, 2026: EPS $1.26 vs $0.96 expected — a beat of 31.3%.
What is LIVN's P/E ratio?
LIVN trades at a P/E of 23.3 vs a Healthcare average of 17.5.
Does LIVN pay a dividend?
LIVN does not currently pay a dividend.
How much debt does LIVN have?
LivaNova PLC reported $290M of debt and $517M of cash (Jun 30, 2026).
What are LIVN support and resistance levels?
Support: $88.00, $82.28, $75.13. Resistance: $93.89, $99.38.
What are insiders doing with LIVN?
Insider activity: NEUTRAL, 0 buys and 3 sells in the last 90 days.
What is the latest news on LIVN?
Nov 9, 2026: Barclays keeps LivaNova at Overweight, lifts price target to $120 · Nov 9, 2026: Barclays keeps Overweight rating on LivaNova, lifts target to $120 · Nov 5, 2026: Baird keeps Outperform rating on LivaNova, lifts price target to $111